- Ngā maimoatanga
- Ngā Whakaaturanga
- Neuroblastoma
- Puku totoka
- Ngā Whakaaturanga
- TIL
- Te Whakaora Pūtau NK
- Te Maistenia Gravis (MG)
- Te Mate Pūkahukahu Lymphoblastic Whakapeka (B-ALL)
- Lupus Erythematosus Pūnaha (SLE)
- Te mate pukupuku lymphoblastic whakapeka (T-ALL)
- Lymphoma Kore-Hodgkin (NHL)
- Myeloma maha (MM)
- Lymphom Pūtau-B Nui e horapa ana
- Leukemia B-lymphocytic
- Myeloma
Te Whakaora CAR-T mō te Mate Pukupuku o te Kōpū
Matepukupuku puku Ko tētahi o ngā mate pukupuku tino noa o te pūnaha nakunaku puta noa i te ao. I te tau 2020, tata ki te 1,089,000 ngā kēhi hou puta noa i te ao, me te tata ki te 769,000 ngā mate e pā ana, ā, he tino teitei ngā reiti mate me te auau mate i Āhia ki te Rawhiti—tae atu ki Haina, Hapani, me Kōrea ki te Tonga. Ahakoa kua heke te reiti whānui i ngā tau tata nei, kei te nui tonu ngā kēhi kua hoki mai me ngā kēhi uaua ki te rongoā, e whakaatu ana i te hiahia nui mō ngā rautaki maimoatanga hou.
He aha te rongoā CAR-T?
Te rongoā CAR-T (pūtau-T kaiwhakawhiwhi antigen chimeric) He huarahi whakaora ārai mate whaiaro tēnei e hangaia ai ngā pūtau-T o te tūroro i roto i te tinana kia puta ai he kaiwhakawhiwhi e mōhio ana ki tētahi ira e pā ana ki te pukupuku.
Kātahi ka whakahokia mai ēnei pūtau kua whakarerekētia ki roto i te tūroro hei rapu me te whakangaro i ngā pūtau matepukupuku. Nā te mea kua tutuki ngā hua hou mō ngā mate pukupuku toto, kei te whakawhānuihia te rongoā CAR-T ki ngā pukupuku totoka pērā i te matepukupuku puku.
Claudin18.2
Ko Claudin18.2 (CLDN18.2) he isoform pūmua hononga piripono e whakaatuhia ana i roto i te epithelium puku, ā, he nui rawa te whakaaturanga i runga i te mata o ngā pūtau matepukupuku puku. Ko CT041 (waehere whanaketanga CG4006) he hua CAR-T autologous e aro ana ki te CLDN18.2. E whakaatu ana ngā raraunga Wāhanga I i te kaha ārai-pukupuku i roto i ngā tūroro matepukupuku puku kua tino rongoatia, he CLDN18.2-pai.
HER2
Ka kitea anō hoki te nui rawa o te HER2 i roto i tētahi rōpū iti o ngā tūroro matepukupuku puku. Kua whakaatuhia e ngā maimoatanga CAR-T e aro ana ki te HER2 te kaha ārai-pukupuku i roto i ngā rangahau haumanu-mua me ngā rangahau haumanu tōmua. Kei roto i ngā whakamātautau haumanu Wāhanga II te TAC01-HER2 a Triumvira Immunologics i tēnei wā.
-
Te Whāinga Tino MotuhakeMā te tuku i ngā pūtau CAR-T ki te CLDN18.2, ki te HER2 rānei, ka taea te tautuhi tika me te whakakore i ngā pūtau matepukupuku o te puku, ka whakaitihia ngā pānga mai i waho o te pukupuku.
-
Te wikitoria i te ātete ki te maimoatanga maha-rainaI roto i ngā whakamātautau CT041, i eke te rōpū matepukupuku puku ki te reiti urupare whāinga (ORR) o te 57.1%, te reiti whakahaere mate (DCR) o te 75.0%, me te oranga whānui (OS) o te 6-marama o te 81.2% i roto i ngā tūroro i rahua i ngā raina rongoā maha o mua.
-
Ngā Urupare PūmauKo te roanga o te urupare mō te 6 marama i puta mai i te maimoatanga CLDN18.2-CAR-T he 44.8%, e whakaatu ana i te kaha ki te whai hua haumanu mō te wā roa.
-
Te Whakaora WhaiaroMā te whakamahi i ngā pūtau-T o te tūroro ka whakaiti i te mōrearea o te whakakorenga, ā, ka whakarei ake i te haumaru me te whai huatanga.
-
Kohinga Pūtau-T Toto Āpiti
Ka wehea ngā pūtau-T i te toto ā-taha o te tūroro mā te leukapheresis. -
Te Hangarau Ira
I roto i tētahi taiwhanga e tutuki ana i ngā whakaritenga GMP, ka whakawhitihia ngā pūtau-T hei whakaatu i tētahi CAR e aro ana ki te CLDN18.2, ki te HER2 rānei, kātahi ka whakawhanuitia ex vivo. -
Te Whakahauora i te Lymphodepleting
Ka tukuna he rongoā whakarite o te cyclophosphamide me te fludarabine hei whakaiti i ngā lymphocytes taketake me te waihanga i tētahi āputa pai mō te whakawhānui i ngā pūtau CAR-T. -
Te Werohanga Pūtau CAR-T
Ka werohia anō ngā pūtau CAR-T kua hangaia ki roto i te tūroro mā te uaua. -
Aroturuki me te Whakahaere
Whai muri i te werohanga, ka tirotirohia tatatia ngā tūroro mō te mate tukunga cytokine (CRS) me te paitini roro, me te wawaotanga i te wā tika ina hiahiatia.
-
Tātaritanga Wāhanga Tuatahi CT041 (CLDN18.2-CAR-T)
I roto i ngā tūroro 37 i mua i te maimoatanga nui, i eke te rōpū matepukupuku puku ki te ORR 57.1%, DCR 75.0%; 94.6% i pāngia e te CRS Tau 1–2 anake, kāore he CRS Tau 3, teitei ake rānei, he paitini roro rānei; ko te roanga o te urupare e 6-marama ko te 44.8%. -
Ngā Hua Whakamutunga o te Wāhanga Tuatahi o Satri-cel (e aro ana hoki ki te CLDN18.2)
I roto i te 98 o ngā tūroro matepukupuku puku he CLDN18.2-pai, ko te ORR he 38.8%, ko te DCR he 91.8%; ko te oranga kore-haere-ake toharite (mPFS) he 4.4 marama (95% CI 3.7–6.6), ko te oranga whānui toharite (mOS) he 8.8 marama (95% CI 7.1–10.2); 96.9% i pāngia e te CRS Taumata 1–2 anake, kāore he CRS Taumata 3+, he mate rānei e pā ana. -
Ngā Raraunga Hauora Moata HER2-CAR-T
I whakaatuhia e te rangahau Wāhanga Tuatahi tuatahi i roto i te tangata he kōtaha haumaru ka taea te whakahaere; kei te haere tonu te whakamātautau rēhitatanga Wāhanga Tuarua.
-
Pūhara Hangarau Ārahi
Kei te whakahaerehia e BIOOCUS tētahi whare hanga rongoā pūtau taumata GMP o te ao, hei whakarite kia pai, kia pumau hoki te hanga pūtau CAR-T. -
Te Rōpū Tohunga Maha-mātauranga
Kei roto i tā mātou tīma ngā tohunga mātau ki te rongoā ārai mate, te mate pukupuku, me te whakaora pūtau, e whakarato ana i te whakahaere whaiaro katoa. -
Wheako Hauora o te Ao
Kua rongoatia e mātou ngā tūroro o te ao katoa, me te kohikohi i ngā raraunga whānui mō te haumaru me te whai huatanga. -
Ratonga Whānui mai i te Mutunga ki te Mutunga
Mai i te hoahoa tikanga me te whakaritenga maimoatanga ki tāwāhi ki te whai i te maimoatanga roa i muri i te werohanga, ka tukuna e BIOOCUS te tautoko kotahi-mutunga.
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

